Moreover, the clinical algorithms developed by MSKCC may well feature diagnostic studies and treatment recommendations that are not readily executed in the places where decision-making support is most needed.

FORBES: Is IBM's Watson in Jeopardy? This Oncologist Thinks So!

The medical recommendations it creates based on a learning process of digesting case histories from Memorial Sloan-Kettering Cancer Center (MSKCC), Cleveland Clinic, and other institutions can only be as good as the data that are input and the decision-making processes it is charged to recreate.

FORBES: Is IBM's Watson in Jeopardy? This Oncologist Thinks So!

There is good reason to be concerned that practicing the broad export of MSKCC-inspired clinical algorithms, which may sometimes appear to have been developed with only a passing nod to compelling clinical evidence and near disdain for fiscal restraint, could be a bit too much like having shopping algorithms inspired by the Kardashians.

FORBES: Is IBM's Watson in Jeopardy? This Oncologist Thinks So!